Argentina implements a regulation to simplify import procedures for Class I & II medical products. 
 

Hong Kong to launch CMPR by 2026, speeding drug approvals via “1+” rules; US$640M fund, ICH alignment boost trials. Strong base for U.S. clinical research.

Portugal’s pharmaceutical market is on a steady growth trajectory.

Portugal’s healthcare sector is undergoing a dynamic transformation,

New Zealand’s infrastructure needs create major opportunities for U.S. firms in energy, healthcare, housing & telecom with demand for resilient solutions.

Burma’s telemedicine sector offers selective growth opportunities, supported by gradual digital adoption and ongoing healthcare demand.

The Philippines’ fast-growing Digital Therapeutics (DTx) market presents strong opportunities for U.S. innovators.

Germany’s FemTech market is rapidly expanding, driven by digital innovation, regulatory support, and demand for personalized healthcare solutions for women.

Australia’s well-developed healthcare system includes public and private hospitals, both offering strong opportunities for U.S. medical suppliers.

Taiwan’s advancing cell and gene therapy (CGT) ecosystem is creating strong partnership opportunities for U.S. companies.

Tanzania allocates budget to strengthen healthcare services

U.S. companies face ongoing delays in Guatemala’s sanitary registration process for medicines and related products, affecting both new applications and renewals

Demand is booming in Brazil for semaglutide generic drugs.  

The Drug Authority designed to help streamline applications and track the process of medical device registration via its online service portal. 

Opening doors for U.S. Medtech and Digital Health Innovation in Ireland’s evolving Healthcare System